SABS
SAB Biotherapeutics, Inc.NASDAQHealthcare$3.85-0.77%ClosedMarket Cap: $36.8M
As of 2026-04-07
Analyst Consensus
Consensus
Buy
Target (Consensus)
$7.00
Target (Median)
$7.00
Target Range
$7.00 - $7.00
Upside from current price: 81.8%
Rating Distribution
0 Strong Buy8 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-11 | Chardan Capital | maintain | Buy | Buy |
| 2026-03-10 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-12-18 | Chardan Capital | maintain | Buy | Buy |
| 2025-11-17 | Chardan Capital | maintain | Buy | Buy |
| 2025-09-19 | Chardan Capital | maintain | Buy | Buy |
| 2025-08-08 | Chardan Capital | maintain | Buy | Buy |
| 2025-07-22 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-05-15 | Chardan Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.45 | $83.3K | 3 |
| Sun Dec 31 | $-0.47 | $11.9M | 6 |
| Mon Dec 31 | $-0.37 | $83.4M | 4 |
| Tue Dec 31 | $-0.03 | $218.5M | 2 |